The latest research from Fore Pharma, Global Thalassemia Market and Competitive Landscape – 2020, provides comprehensive insights into Thalassemia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Thalassemia market size and drug sales. It also provides insights into Thalassemia epidemiology and late stage pipeline.
This research covers the following – Thalassemia treatment options, Thalassemia late stage clinical trials pipeline, Thalassemia prevalence by countries, Thalassemia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Thalassemia pipeline: Find out drugs in clinical trials for Thalassemia by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Thalassemia epidemiology: Find out number of patients diagnosed (prevalence) with Thalassemia by countries
– Thalassemia drugs: Identify key drugs marketed and prescribed for Thalassemia by countries, including trade name, molecule name, and company
– Thalassemia drugs sales: Find out the sales value for Thalassemia drugs by countries
– Thalassemia market valuations: Find out the market size for Thalassemia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Thalassemia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Thalassemia drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Thalassemia market
– Develop in-depth knowledge of competition and markets
– Analyze Thalassemia drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Thalassemia market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Thalassemia Treatment Options
2. Thalassemia Pipeline Insights
2.1. Thalassemia Phase 3 Clinical Trials
2.2. Thalassemia Phase 2 Clinical Trials
2.3. Thalassemia Phase 1 Clinical Trials
3. Thalassemia Epidemiology Analysis by Countries
4. US Thalassemia Market Insights
4.1. Marketed Drugs for Thalassemia in US
4.2. US Thalassemia Market Size & Forecast
4.3. US Thalassemia Drugs Sales & Forecast
4.4. US Thalassemia Market Share Analysis
5. Germany Thalassemia Market Insights
5.1. Marketed Drugs for Thalassemia in Germany
5.2. Germany Thalassemia Market Size & Forecast
5.3. Germany Thalassemia Drugs Sales Forecast
5.4. Germany Thalassemia Market Share Analysis
6. France Thalassemia Market Insights
6.1. Marketed Drugs for Thalassemia in France
6.2. France Thalassemia Market Size & Forecast
6.3. France Thalassemia Product Sales Forecast
6.4. France Thalassemia Market Share Analysis
7. Italy Thalassemia Market Insights
7.1. Marketed Drugs for Thalassemia in Italy
7.2. Italy Thalassemia Market Size & Forecast
7.3. Italy Thalassemia Product Sales Forecast
7.4. Italy Thalassemia Market Share Analysis
8. Spain Thalassemia Market Insights
8.1. Marketed Drugs for Thalassemia in Spain
8.2. Spain Thalassemia Market Size & Forecast
8.3. Spain Thalassemia Product Sales Forecast
8.4. Spain Thalassemia Market Share Analysis
9. UK Thalassemia Market Insights
9.1. Marketed Drugs for Thalassemia in UK
9.2. UK Thalassemia Market Size & Forecast
9.3. UK Thalassemia Product Sales Forecast
9.4. UK Thalassemia Market Share Analysis
10. Europe Thalassemia Market Insights
10.1. Europe Thalassemia Market Size & Forecast
10.2. Europe Thalassemia Product Sales Forecast
10.3. Europe Thalassemia Market Share Analysis
11. Japan Thalassemia Market Insights
11.1. Marketed Drugs for Thalassemia in Japan
11.2. Japan Thalassemia Market Size & Forecast
11.3. Japan Thalassemia Product Sales Forecast
11.4. Japan Thalassemia Market Share Analysis
12. Global Thalassemia Market Insights
12.1. Global Thalassemia Market Size & Forecast
12.2. Global Thalassemia Product Sales Forecast
12.3. Global Thalassemia Market Share Analysis
13. Research Methodology
List of Tables
1: Thalassemia Phase 3 Clinical Trials, Global, 2020
2: Thalassemia Phase 2 Clinical Trials, Global, 2020
3: Thalassemia Phase 1 Clinical Trials, Global, 2020
4: Thalassemia Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Thalassemia in US, 2019
6: US Thalassemia Market Size & Forecast ($mn), 2016 – 2025
7: US Thalassemia Product Sales ($mn), 2016 – 2025
8: US Thalassemia Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Thalassemia in Germany, 2019
10: Germany Thalassemia Market Size & Forecast ($mn), 2016 – 2025
11: Germany Thalassemia Product Sales ($mn), 2016 – 2025
12: Germany Thalassemia Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Thalassemia in France, 2019
14: France Thalassemia Market Size & Forecast ($mn), 2016 – 2025
15: France Thalassemia Product Sales ($mn), 2016 – 2025
16: France Thalassemia Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Thalassemia in Italy, 2019
18: Italy Thalassemia Market Size & Forecast ($mn), 2016 – 2025
19: Italy Thalassemia Product Sales ($mn), 2016 – 2025
20: Italy Thalassemia Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Thalassemia in Spain, 2019
22: Spain Thalassemia Market Size & Forecast ($mn), 2016 – 2025
23: Spain Thalassemia Product Sales ($mn), 2016 – 2025
24: Spain Thalassemia Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Thalassemia in UK, 2019
26: UK Thalassemia Market Size & Forecast ($mn), 2016 – 2025
27: UK Thalassemia Product Sales ($mn), 2016 – 2025
28: UK Thalassemia Market Events and Trends, 2016 – 2025
29: Europe Thalassemia Market Size & Forecast ($mn), 2016 – 2025
30: Europe Thalassemia Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Thalassemia in Japan, 2019
32: Japan Thalassemia Market Size & Forecast ($mn), 2016 – 2025
33: Japan Thalassemia Product Sales ($mn), 2016 – 2025
34: Japan Thalassemia Market Events and Trends, 2016 – 2025
35: Global Thalassemia Market Size & Forecast ($mn), 2016 – 2025
36: Global Thalassemia Product Sales ($mn), 2016 – 2025
List of Figures
1: Thalassemia Pipeline by Phase (%), Global, 2020
2: Thalassemia Prevalence by Countries, 2016 – 2025
3: US Thalassemia Market Size ($mn), 2016 – 2025
4: US Thalassemia Product Sales ($mn), 2016 – 2025
5: US Thalassemia Market Share by Drugs (%), 2019
6: US Thalassemia Market – Future Market Share (%), 2025
7: Germany Thalassemia Market Size ($mn), 2016 – 2025
8: Germany Thalassemia Product Sales ($mn), 2016 – 2025
9: Germany Thalassemia Market Share by Drugs (%), 2019
10: Germany Thalassemia Market – Future Market Share (%), 2025
11: France Thalassemia Market Size ($mn), 2016 – 2025
12: France Thalassemia Product Sales ($mn), 2016 – 2025
13: France Thalassemia Market Share by Drugs (%), 2019
14: France Thalassemia Market – Future Market Share (%), 2025
15: Italy Thalassemia Market Size ($mn), 2016 – 2025
16: Italy Thalassemia Product Sales ($mn), 2016 – 2025
17: Italy Thalassemia Market Share by Drugs (%), 2019
18: Italy Thalassemia Market – Future Market Share (%), 2025
19: Spain Thalassemia Market Size ($mn), 2016 – 2025
20: Spain Thalassemia Product Sales ($mn), 2016 – 2025
21: Spain Thalassemia Market Share by Drugs (%), 2019
22: Spain Thalassemia Market – Future Market Share (%), 2025
23: UK Thalassemia Market Size ($mn), 2016 – 2025
24: UK Thalassemia Product Sales ($mn), 2016 – 2025
25: UK Thalassemia Market Share by Drugs (%), 2019
26: UK Thalassemia Market – Future Market Share (%), 2025
27: Europe Thalassemia Market Size ($mn), 2016 – 2025
28: Europe Thalassemia Product Sales ($mn), 2016 – 2025
29: Europe Thalassemia Market Share by Drugs (%), 2019
30: Europe Thalassemia Market – Future Market Share (%), 2025
31: Japan Thalassemia Market Size ($mn), 2016 – 2025
32: Japan Thalassemia Product Sales ($mn), 2016 – 2025
33: Japan Thalassemia Market Share by Drugs (%), 2019
34: Japan Thalassemia Market – Future Market Share (%), 2025
35: Global Thalassemia Market Size ($mn), 2016 – 2025
36: Global Thalassemia Product Sales ($mn), 2016 – 2025
37: Global Thalassemia Market Share by Drugs (%), 2019
38: Global Thalassemia Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.